Identification of Potential Biomarkers for Progression and Prognosis of Bladder Cancer by Comprehensive Bioinformatics Analysis

Figure 5

The correlation analysis of characteristic genes with clinicopathological features. (a) Expression of SMYD2 between different pathological grades. (b–d) GAPDHP1 expression between different clinical stages, pathological grades, and T stages. (e–h) Expression of CILP between different clinical stages, pathological grades, T stages, and N stages. (i) Expression of ATP1A2 in different N stages. (j–l) Expression of THSD4 in different ages, clinical stages, and T stages.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)